🇺🇸 FDA
Patent

US 10717764

Therapeutically active compounds and their methods of use

granted A61KA61K38/005A61K38/05

Quick answer

US patent 10717764 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/005, A61K38/05, A61K45/06, A61P